Vice President Of Business Development
Current
Oct 2024 - Present
AeroLeads people directory · profile
David Perry Email & Phone Number
Corporate Business Development | Strategy | M&A | Licensing | JV | Divestments | Partnerships | Due Diligence | Negotiations | Financial Analysis | Complex Transactions | Deal Execution | Pharma | Biotech | Life Science
at
Aligos Therapeutics
1 work email found
@apexigen.com
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Corporate Business Development | Strategy | M&A | Licensing | JV | Divestments | Partnerships | Due Diligence | Negotiations | Financial Analysis | Complex Transactions | Deal Execution | Pharma | Biotech | Life Science
Location
San Francisco, California, United States
Who is David Perry? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
David Perry is listed as Corporate Business Development | Strategy | M&A | Licensing | JV | Divestments | Partnerships | Due Diligence | Negotiations | Financial Analysis | Complex Transactions | Deal Execution | Pharma | Biotech | Life Science at Aligos Therapeutics, based in San Francisco, California, United States. AeroLeads shows a work email signal at apexigen.com and a matched LinkedIn profile for David Perry.
David Perry previously worked as Vice President of Business Development at Aligos Therapeutics and Senior Director, Business Development at Sangamo Therapeutics, Inc.. David Perry holds Bs, Environmental Engineering from Tufts University.
Company email context
Email format at Aligos Therapeutics
This section adds company-level context without repeating David Perry's masked contact details.
{first_initial}{last}@apexigen.com
86% confidence
AeroLeads found 1 current-domain work email signal for David Perry. Compare company email patterns before reaching out.
Profile bio
About David Perry
Analytical and strategy-minded professional with extensive experience in corporate business development transactions, strategy, start-up investments, M&A, and alliance management. Adept at leveraging a blend of business, product, platform technology, and portfolio expertise supporting multi-national biopharmaceutical and life science companies. Skilled in the evaluation of multi-faceted, complex transaction structures, leading the deal lifecycle from strategy development to successful negotiation, building business cases for stakeholder buy-in at the C-suite and board-level, and maintaining strong relationships with third-party partners. A deal sheet that includes both buy- and sell-side licensing (for platform technologies and clinical-stage programs), M&A, non-dilutive financing, limited partner investments, and asset purchase. Recognized for leading collaborative cross-functional teams, engaging stakeholders, and maintaining an accessible network of professionals and information sources, including inventors, academics, trade group leaders, industry peers, consultants, sell-side bankers, venture capital and media contacts. Areas of therapeutic interest and experience include: oncology (i.e. small molecules), immuno-oncology (i.e. antibodies and antibody drug conjugate), cell and gene therapy, genomic engineering, ophthalmology, CNS, neurology, and autoimmune.
Listed skills include Start Ups, Business Development, Pharmaceutical Industry, Venture Capital, and 9 others.
Current workplace
David Perry's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles
David Perry work experience
A career timeline built from the work history available for this profile.
Senior Director, Business Development
Responsible for new business development, strategic partnerships, and IP monetization in the area of cell and gene therapy related to Sangamo’s zinc finger genome engineering and AAV capsid delivery platforms. Led-to-close a license transaction with Genentech, valued at $1.9 billion, in August 2024.
Aug 2023 - Oct 2024
Senior Director, Business Development Lead
Lead Apexigen's business development strategy and execution efforts - focused on licensing our clinical-stage oncology assets and antibody discovery platform. Responsible for the structuring, negotiating, and closing of strategic partnering transaction agreements and post-closing alliance management in immuno-oncology. Acquired by Pyxis Oncology in August.
Apr 2022 - Jul 2023
Senior Director Corporate Venturing
Lead early-stage, strategic capital investments, ranging from $250K to $2M, in emerging life science companies, including sectors such as cell and gene therapy, AI-drug discovery, alternative protein, and natural product delivery systems.
Apr 2020 - Apr 2022
Director Business Development
Accelerated growth via acquisitions and strategic investments in multi-national commercial-stage, life science-focused companies. Established corporate development processes and growth strategy, hired BD-group members, and managed the entire deal lifecycle including the identification, structuring, and negotiation of globally strategic collaborations and.
Oct 2015 - Apr 2020
Director Business Development
Headed business development for multi-national specialty generic pharmaceutical company and subsidiary, focused on the areas of oncology and cardiovascular disease. Drove end-to-end deals, targeting $500M+ in potential product collaboration value, via licensing and asset acquisition.
Apr 2014 - Aug 2015
Business Development Consultant
Independent
Interfaced as lead business development team member, developing and driving partnering strategies. Retained by biopharmaceutical companies to assume complete responsibility for executing deals and continuously improving the entire business development process from search and identification through due diligence and closing.
Jan 2011 - Apr 2014
Business Development Lead
Initially retained as a consultant to complete the acquisition of a manufacturing business unit, with expertise in drug delivery for dermatological and respiratory diseases. Subsequently hired to restructure the newly acquired business and transform it into an integrated specialty pharmaceutical company. A “white space” opportunity to build a sustainable.
Nov 2005 - Jan 2008
Business Development Lead
Bioneutral Labs Usa
Hired to co-direct all phases and initiatives of this new start-up venture including, the IP transfer, building corporate infrastructure, creating the business plan, and financing strategy. Closed seed investment of $2M. The areas of focus: infectious disease.
May 2004 - Nov 2005
Director Business Development
Hired as a member of a new US-based business development team – formed to both support UK operations and establish new sources of revenue. Identified, structured and negotiated complex technology and product-based transactions, via in/out-licensing, as well as portfolio divestments in the areas of oncology, CNS, and respiratory disease.
Apr 2001 - May 2004
Jun 1998 - Apr 2001
Jun 1996 - Jun 1998
2 education records
David Perry education
Bs, Environmental Engineering
Tufts University
Executive Education, Negotiation And Influence
University Of California, Berkeley, Haas School Of Business
FAQ
Frequently asked questions about David Perry
Quick answers generated from the profile data available on this page.
What company does David Perry work for?
David Perry works for Aligos Therapeutics.
What is David Perry's role at Aligos Therapeutics?
David Perry is listed as Corporate Business Development | Strategy | M&A | Licensing | JV | Divestments | Partnerships | Due Diligence | Negotiations | Financial Analysis | Complex Transactions | Deal Execution | Pharma | Biotech | Life Science at Aligos Therapeutics.
What is David Perry's email address?
AeroLeads has found 1 work email signal at @apexigen.com for David Perry at Aligos Therapeutics.
Where is David Perry based?
David Perry is based in San Francisco, California, United States while working with Aligos Therapeutics.
What companies has David Perry worked for?
David Perry has worked for Aligos Therapeutics, Sangamo Therapeutics, Inc., Apexigen, Sumitomo Chemical: Group Companies Of The Americas, and Twi Pharmaceuticals, Inc..
How can I contact David Perry?
You can use AeroLeads to view verified contact signals for David Perry at Aligos Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did David Perry attend?
David Perry holds Bs, Environmental Engineering from Tufts University.
What skills is David Perry known for?
David Perry is listed with skills including Start Ups, Business Development, Pharmaceutical Industry, Venture Capital, Strategic Planning, Biotechnology, Leadership, and Analysis.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial